Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models

被引:48
作者
Hsieh, Meng Hsuen [1 ]
Sun, Li-Min [2 ]
Lin, Cheng-Li [3 ,4 ]
Hsieh, Meng-Ju [5 ]
Hsu, Chung-Y [6 ]
Kao, Chia-Hung [6 ,7 ,8 ,9 ]
机构
[1] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA
[2] Kaohsiung Armed Forces Gen Hosp, Zuoying Branch, Dept Radiat Oncol, Kaohsiung, Taiwan
[3] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[4] China Med Univ, Coll Med, Taichung, Taiwan
[5] Poznan Univ Med Sci, Dept Med, Poznan, Poland
[6] China Med Univ, Grad Inst Biomed Sci, 2 Yuh Der Rd, Taichung 404, Taiwan
[7] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan
[8] China Med Univ Hosp, PET Ctr, Taichung, Taiwan
[9] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan
关键词
pancreatic cancer; type; 2; diabetes; logistic regression; artificial neural network; POPULATION-BASED COHORT; RISK-FACTORS; EPIDEMIOLOGY; INDEX;
D O I
10.2147/CMAR.S180791
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Patients with type 2 diabetes (T2DM) arc suggested to have a higher risk of developing pancreatic cancer. We used two models to predict pancreatic cancer risk among patients with T2DM. Methods: The original data used for this investigation were retrieved from the National Health Insurance Research Database of Taiwan. The prediction models included the available possible risk factors for pancreatic cancer. The data were split into training and test sets: 97.5% of the data were used as the training set and 2.5% of the data were used as the test set. Logistic regression (LR) and artificial neural network (ANN) models were implemented using Python (Version 3.7.0). The F-1, precision, and recall were compared between the LR and the ANN models. The areas under the receiver operating characteristic (ROC) curves of the prediction models were also compared. Results: The metrics used in this study indicated that the I,R model more accurately predicted pancreatic cancer than the ANN model. For the LR model, the area under the ROC curve in the prediction of pancreatic cancer was 0.727, indicating a good fit. Conclusion: Using this LR model, our results suggested that we could appropriately predict pancreatic cancer risk in patients with T2DM in Taiwan.
引用
收藏
页码:6317 / 6324
页数:8
相关论文
共 37 条
[1]  
Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265
[2]  
[Anonymous], 2005, MOL CANCER, DOI DOI 10.1186/1476-5498-4-29
[3]  
[Anonymous], 2015, IEEE I CONF COMP VIS, DOI DOI 10.1109/ICCV.2015.123
[4]  
[Anonymous], CANC STAT ANN REP
[5]   Informatics in Radiology Comparison of Logistic Regression and Artificial Neural Network Models in Breast Cancer Risk Estimation [J].
Ayer, Turgay ;
Chhatwal, Jagpreet ;
Alagoz, Oguzhan ;
Kahn, Charles E., Jr. ;
Woods, Ryan W. ;
Burnside, Elizabeth S. .
RADIOGRAPHICS, 2010, 30 (01) :13-U27
[6]   Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection [J].
Becker, Andrew E. ;
Hernandez, Yasmin G. ;
Frucht, Harold ;
Lucas, Aimee L. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (32) :11182-11198
[7]  
Cancer Statistics, CANC INC TRENDS TAIW
[8]   The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study [J].
Carreras-Torres, Robert ;
Johansson, Mattias ;
Gaborieau, Valerie ;
Haycock, Philip C. ;
Wade, Kaitlin H. ;
Relton, Caroline L. ;
Martin, Richard M. ;
Smith, George Davey ;
Brennan, Paul .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (09)
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]   Statins and the risk of pancreatic cancer in Type 2 diabetic patients-A population-based cohort study [J].
Chen, Mei-Jyh ;
Tsan, Yu-Tse ;
Liou, Jyh-Ming ;
Lee, Yi-Chia ;
Wu, Ming-Shiang ;
Chiu, Han-Mo ;
Wang, Hsiu-Po ;
Chen, Pau-Chung .
INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (03) :594-603